Abstract:BACKGROUND: Curcumin is a kind of plant polyphenol that is extracted from the rhizome of Curcuma longa. Studies about the effect of curcumin on the activity of drug-metabolizing enzymes in humans are lacking. OBJECTIVE: To investigate the effect of curcumin on the activities of CYP1A2, CYP2A6, N-acetyltransferase (NAT2), and xanthine oxidase (XO) in vivo, using caffeine as a probe drug. METHOD: Sixteen unrelated, healthy Chinese men were recruited for the study. There were 2 phases in the study. In the first phase, volunteers orally received 100 mg caffeine and 0- to 12-hour blood and urine samples were collected. In the second phase, volunteers received 1000 mg curcumin once daily for 14 continuous days, and blood and urine samples were collected on day 15, following the same procedure used on the first day. Urinary caffeine metabolite ratios were used as the indicators of the activities of CYP1A2, CYP2A6, NAT2, and XO. The pharmacokinetics of caffeine and its metabolites were determined by high-performance liquid chromatography. RESULTS: In the curcumin-treated group, CYP1A2 activity was decreased by 28.6% (95% CI 15.6 to 41.8; p < 0.000), while increases were observed in CYP2A6 (by 48.9%; 95% CI 25.3 to 72.4; p < 0.000). Plasma area under the curve from zero to 12 hours of 1,7-dimethylxanthine (17X) was decreased by 27.2% (95% CI 6.1 to 48.3; p = 0.014). The urinary excretion of 17X and 1-methylxanthine was significantly decreased by 36.4% (95% CI 19.4 to 53.6; p < 0.000) and 31.2% (95% CI 8.5 to 54.1; p = 0.010), respectively. The excretion of 1,7-dimethylurate (17U) was significantly increased by 77.3% (95% CI 5.6 to 148.8; p = 0.036). No significant changes were observed for caffeine, 1-methylurate, and 5-acetylamino-6-formylamino-3-methyluracil between the 2 study phases. CONCLUSIONS: The results indicated that curcumin inhibits CYP1A2 function but enhances CYP2A6 activity. Simultaneously, some pharmacokinetic parameters relating to 17X were affected by curcumin. If this finding is confirmed by other studies, the possibility of herb-drug interactions associated with curcumin should be considered in clinical practice.

Effects of Curcumin on the Pharmacokinetics of Talinolol in Human with ABCB1 Polymorphism.

Unexpected Effect of Concomitantly Administered Curcumin on the Pharmacokinetics of Talinolol in Healthy Chinese Volunteers

Effect of duloxetine on the pharmacokinetics of talinolol in humans

Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.

Mdr1 Genotype Do Not Influence the Absorption of A Single Oral Dose of 100 Mg Talinolol in Healthy Chinese Males

The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.

Effect of Schisandra Chinensis Extract and Ginkgo Biloba Extract on the Pharmacokinetics of Talinolol in Healthy Volunteers.

Effects of Regular Consumption of RRR-tocopherol on the Activity of CYP3A 4 in Vivo

Effect of Quercetin on P-glycoprotein Transport Ability in Chinese Healthy Subjects

Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers.

Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers.

Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants

Effect of Bifendate on the Pharmacokinetics of Talinolol in Healthy Subjects

Effects of Curcumin on the Pharmacokinetics of Loratadine in Rats: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Curcumin

CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects

Lack of Effect of Continuous Glycyrrhizin Administration on the Pharmacokinetics of the P-Glycoprotein Substrate Talinolol in Healthy Volunteers

Influences of ABCB1 polymorphism on the dose adjusted blood concentration of tacrolimus and renal function in renal transplant recipients with cytochrome P450 3A5 * 3/* 3 genotype

Effect of CYP3A5*3 Polymorphism on Pharmacokinetic Drug Interaction Between Tacrolimus and Amlodipine

Plant Polyphenol Curcumin Significantly Affects CYPIA2 and CYP2A6 Activity in Healthy, Male Chinese Volunteers

The Effect of Herbal Medicine Baicalin on Pharmacokinetics of Rosuvastatin, Substrate of Organic Anion‐transporting Polypeptide 1B1

Polymorphism Of Orm1 Is Associated With The Pharmacokinetics Of Telmisartan